[HTML] frontiersin.org

[HTML][HTML] Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas

EJ Medina, YM Zohdy, E Porto… - Frontiers in …, 2023 - frontiersin.org
Introduction Aggressive prolactinomas (APRLs) pose a significant clinical challenge due to
their high rate of regrowth and potentially life-threatening complications. In this study, we …
相关文章
[HTML] nih.gov

[HTML][HTML] Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas

EJ Medina, YM Zohdy, E Porto… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods A total of 268 articles were reviewed and 46 were included. Case reports and
series, and studies that investigated the molecular and/or genetic analysis of APRLs were …
[PDF] researchgate.net

[PDF][PDF] Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas

EJ Medina, YM Zohdy, E Porto, JMR Barbero, D Bray… - 2023 - researchgate.net
Methods: A total of 268 articles were reviewed and 46 were included. Case reports and
series, and studies that investigated the molecular and/or genetic analysis of APRLs were …

Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas

EJ Medina, YM Zohdy, E Porto… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Aggressive prolactinomas (APRLs) pose a significant clinical challenge due to
their high rate of regrowth and potentially life-threatening complications. In this study, we …

Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.

EJ Medina, YM Zohdy, E Porto, RB JM… - Frontiers in …, 2023 - europepmc.org
Aggressive prolactinomas (APRLs) pose a significant clinical challenge due to their high
rate of regrowth and potentially life-threatening complications. In this study, we present a …